Literature DB >> 7817208

A qualitative approach to defining "hot flashes" in men.

S Quella, C L Loprinzi, A M Dose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7817208

Source DB:  PubMed          Journal:  Urol Nurs        ISSN： 1053-816X


× No keyword cloud information.
  4 in total

Review 1.  Androgen deprivation therapy-associated vasomotor symptoms.

Authors:  Jason M Jones; Manish Kohli; Charles L Loprinzi
Journal:  Asian J Androl       Date:  2012-01-30       Impact factor: 3.285

2.  Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

Authors:  Amanda R Moraska; Pamela J Atherton; Daniel W Szydlo; Debra L Barton; Philip J Stella; Kendrith M Rowland; Paul L Schaefer; James Krook; James D Bearden; Charles L Loprinzi
Journal:  J Support Oncol       Date:  2010 May-Jun

3.  A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

Authors:  C L Loprinzi; A C Dueck; B S Khoyratty; D L Barton; S Jafar; K M Rowland; P J Atherton; G W Marsa; W H Knutson; J D Bearden; L Kottschade; T R Fitch
Journal:  Ann Oncol       Date:  2009-01-06       Impact factor: 32.976

4.  Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.

Authors:  Mara Z Vitolins; Leah Griffin; W Vic Tomlinson; Jacqueline Vuky; Paul T Adams; Dawn Moose; Bart Frizzell; Glenn J Lesser; Michelle Naughton; James E Radford; Edward G Shaw
Journal:  J Clin Oncol       Date:  2013-09-30       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.